U.S. Capital Wealth Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $486K | Buy |
4,529
+326
| +8% | +$35K | 0.01% | 602 |
|
|
2025
Q1 | $424K | Buy |
4,203
+480
| +13% | +$48.4K | 0.01% | 620 |
|
|
2024
Q4 | $333K | Buy |
3,723
+829
| +29% | +$74K | 0.01% | 658 |
|
|
2024
Q3 | $243K | Sell |
2,894
-498
| -15% | -$41.7K | 0.01% | 634 |
|
|
2024
Q2 | $261K | Sell |
3,392
-529
| -13% | -$40.7K | 0.01% | 592 |
|
|
2024
Q1 | $269K | Sell |
3,921
-769
| -16% | -$52.7K | 0.01% | 587 |
|
|
2023
Q4 | $271K | Sell |
4,690
-411
| -8% | -$23.8K | 0.01% | 575 |
|
|
2023
Q3 | $269K | Sell |
5,101
-196
| -4% | -$10.3K | 0.01% | 546 |
|
|
2023
Q2 | $287K | Buy |
5,297
+532
| +11% | +$28.8K | 0.01% | 544 |
|
|
2023
Q1 | $238K | Buy |
4,765
+821
| +21% | +$41.1K | 0.01% | 579 |
|
|
2022
Q4 | $182K | Buy |
+3,944
| New | +$182K | 0.01% | 624 |
|